Apollo Hospitals Enterprise Ltd

₹ 4,728 0.01%
08 Dec 9:33 a.m.
About

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.

Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,
Primary Care & Diagnostic Clinics and several Retail Health models. [1]

Key Points

Healthcare Business (53% of revenues)
Company's healthcare business has a capacity of 10,261 beds in 71 facilities located in India and overseas. Of the 71 facilities, 45 are self owned hospitals, 10 are cradles, 11 are day care/short surgical stay centres and 5 are hospitals under management.

Apollo Hospitals has facilities located in large urban centers such as Chennai, Hyderabad, Kolkata, Bengaluru, New Delhi, Ahmedabad, Mumbai, Pune, Bhubaneshwar, Madurai and Mysore among others. Presently, The company's facilities functions at comfortable utilization rates at around 69-70% [1].

  • Market Cap 67,979 Cr.
  • Current Price 4,728
  • High / Low 5,386 / 3,362
  • Stock P/E 81.0
  • Book Value 417
  • Dividend Yield 0.25 %
  • ROCE 17.8 %
  • ROE 16.6 %
  • Face Value 5.00

Pros

  • Company has delivered good profit growth of 44.8% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 21.0%

Cons

  • Stock is trading at 11.3 times its book value
  • Company has a low return on equity of 10.0% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
2,841 2,912 2,922 2,172 2,761 2,760 2,868 3,760 3,717 3,639 3,546 3,796 4,251
2,427 2,482 2,542 2,159 2,470 2,370 2,456 3,244 3,102 3,052 3,083 3,317 3,699
Operating Profit 413 430 380 13 291 390 412 516 615 587 463 479 552
OPM % 15% 15% 13% 1% 11% 14% 14% 14% 17% 16% 13% 13% 13%
9 10 203 8 47 21 63 319 8 23 34 16 23
Interest 134 137 135 127 122 101 99 95 95 94 95 93 93
Depreciation 155 157 164 160 149 125 138 141 145 149 166 148 155
Profit before tax 134 145 284 -267 66 185 238 599 383 367 236 254 327
Tax % 38% 38% 26% 15% 10% 28% 28% 16% 30% 34% 59% -27% 35%
Net Profit 83 90 210 -226 59 134 170 501 267 243 97 324 213
EPS in Rs 6.20 6.62 15.77 -14.96 4.33 9.38 11.67 34.03 17.24 15.88 6.27 22.05 14.19
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
2,605 3,148 3,769 4,357 5,129 6,150 7,256 8,243 9,617 11,247 10,560 14,663 15,232
2,183 2,631 3,157 3,681 4,392 5,465 6,522 7,442 8,548 9,656 9,420 12,474 13,151
Operating Profit 422 517 612 676 737 684 734 801 1,070 1,591 1,140 2,189 2,081
OPM % 16% 16% 16% 16% 14% 11% 10% 10% 11% 14% 11% 15% 14%
12 22 33 18 47 92 60 24 26 222 103 368 95
Interest 78 89 103 119 118 180 257 295 327 533 449 379 374
Depreciation 95 124 142 168 212 264 314 359 396 620 573 601 618
Profit before tax 261 326 399 407 455 332 222 171 373 660 221 1,578 1,184
Tax % 33% 35% 26% 25% 29% 29% 41% 65% 47% 34% 38% 30%
Net Profit 182 218 303 315 335 235 131 60 200 432 137 1,108 877
EPS in Rs 14.75 16.31 21.88 22.77 24.43 16.99 15.88 8.44 16.96 32.70 10.46 73.42 58.39
Dividend Payout % 25% 25% 25% 25% 24% 35% 38% 59% 35% 18% 29% 16%
Compounded Sales Growth
10 Years: 17%
5 Years: 15%
3 Years: 15%
TTM: 16%
Compounded Profit Growth
10 Years: 14%
5 Years: 45%
3 Years: 62%
TTM: 8%
Stock Price CAGR
10 Years: 19%
5 Years: 32%
3 Years: 50%
1 Year: -11%
Return on Equity
10 Years: 8%
5 Years: 8%
3 Years: 10%
Last Year: 17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
62 67 70 70 70 70 70 70 70 70 72 72 72
Reserves 1,768 2,401 2,677 2,907 3,101 3,261 3,240 3,182 3,264 3,270 4,531 5,551 5,921
957 817 1,213 1,344 1,992 2,834 3,125 3,427 3,673 3,596 4,160 4,068 3,998
815 698 854 1,029 1,297 1,195 1,668 1,917 2,159 4,354 2,629 3,493 3,984
Total Liabilities 3,602 3,983 4,814 5,350 6,459 7,360 8,103 8,596 9,166 11,289 11,392 13,184 13,975
1,530 2,011 2,341 2,681 3,244 3,997 4,591 4,773 4,982 7,432 6,778 8,269 8,256
CWIP 361 209 403 491 533 562 347 712 822 236 234 46 548
Investments 502 564 527 322 311 352 406 352 462 434 1,343 780 631
1,210 1,198 1,543 1,855 2,372 2,448 2,759 2,759 2,901 3,187 3,037 4,090 4,540
Total Assets 3,602 3,983 4,814 5,350 6,459 7,360 8,103 8,596 9,166 11,289 11,392 13,184 13,975

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
259 387 443 373 470 597 623 537 905 1,293 1,265 1,628
-441 -468 -733 -356 -759 -888 -1,152 -405 -711 -289 -880 -678
47 135 373 -63 392 330 477 -108 -215 -910 -340 -793
Net Cash Flow -136 54 83 -46 103 39 -52 24 -20 94 44 158

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 42 45 46 44 43 36 38 37 39 33 46 44
Inventory Days 44 45 43 47 50 49 47 51 46 49 16 21
Days Payable 77 58 53 55 59 66 51 55 56 60 74 79
Cash Conversion Cycle 9 31 36 36 34 19 34 33 29 22 -12 -14
Working Capital Days 13 18 17 28 30 27 30 25 16 9 12 13
ROCE % 13% 14% 13% 12% 12% 9% 8% 7% 10% 14% 8% 18%

Shareholding Pattern

Numbers in percentages

7 recently
Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
30.80 30.81 30.82 30.82 30.82 29.82 29.82 29.82 29.33 29.33 29.33 29.33
48.84 46.92 46.58 47.81 51.70 54.51 53.23 51.54 52.41 50.81 48.48 49.09
13.35 14.78 15.11 14.71 10.85 9.25 10.85 12.28 12.17 12.93 15.64 15.28
0.23 0.23 0.23 0.23 0.23 0.23 0.23 0.23 0.23 0.23 0.23 0.23
6.77 7.25 7.26 6.43 6.40 6.20 5.88 6.14 5.86 6.70 6.32 6.07

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents

Concalls